Description

Diclofenac Sodium & Serratiopeptidase Tablets

Healthy Inc is a specialized global supplier and exporter of advanced orthopedic, surgical, and traumatology therapeutics. We provide ultra-high-purity, kinetically segregated Diclofenac Sodium (50 mg) & Serratiopeptidase (10 mg / 15 mg Enteric-Coated) Tablets, manufactured in WHO–GMP certified, high-precision modified-release facilities. This “Dual-Action NSAID & Proteolytic Synergy” is a massive-volume, high-priority export to orthopedic trauma centers, dental clinics, sports medicine networks, and government health ministries in LATAM, the Middle East, Africa, and Southeast Asia, serving as the globally trusted, hepatotoxic-sparing intervention for severe localized pain and post-surgical tissue swelling.

Product Overview

This highly targeted Dual-FDC masterfully synchronizes a potent peripheral Non-Steroidal Anti-Inflammatory Drug (NSAID) with a powerful biological proteolytic enzyme, delivering surgical-grade healing without the heavy hepatic burden of central analgesics.

The “Pure Peripheral Pain & Edema” Specialist:

• Mechanism 1 (The Inflammatory Blocker – Diclofenac Sodium 50mg): Diclofenac aggressively inhibits COX enzymes at the site of tissue injury, halting the production of pain-inducing prostaglandins. (Note: The Sodium salt of Diclofenac is utilized here, which absorbs slightly slower than the Potassium salt, providing a more sustained, longer-lasting anti-inflammatory baseline for chronic tissue recovery).
• Mechanism 2 (The Proteolytic Edema Drain – Serratiopeptidase 10mg/15mg): Derived from the enterobacterium Serratia, this biological enzyme travels directly to the trauma site. It literally digests dead tissue, blood clots, and inflammatory fluids (fibrin). By rapidly draining this localized fluid (edema), it physically removes the pressure from the surrounding nerves, vastly accelerating the surgical or traumatic healing process.
• The Hepatotoxic-Sparing Advantage: Because this formulation contains zero Paracetamol (Acetaminophen), it eliminates the risk of acute liver toxicity. This makes it the preferred prescription for patients who require prolonged anti-inflammatory therapy or those who regularly consume alcohol.

Product Composition & Strength

We supply this product as a Precision-Engineered Multi-Particulate or Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the sensitive biological enzyme.

*Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for 7-to-14 day post-operative or orthopedic recovery regimens).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Orthopedic Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Enteric Enzymatic Segregation Engineering: Serratiopeptidase is instantly destroyed by stomach acid. Our facilities utilize advanced Fluid Bed Processor (FBP) technology to coat the Serratiopeptidase granules with strict pH-dependent methacrylic polymers (Enteric Coating) before blending them with the Diclofenac Sodium. This guarantees the NSAID dissolves in the stomach for baseline relief, while the enzyme safely bypasses the acid and releases purely in the alkaline intestine.

Therapeutic Indications (Human Use)

Indicated for the targeted eradication of severe pain accompanied by localized tissue swelling:

• Post-Operative Trauma: Pain and severe edema following orthopedic surgeries, maxillofacial surgeries, and complex dental extractions.
• Musculoskeletal Trauma: Severe sports injuries, sprains, strains, fractures, and crush injuries where localized swelling is impeding recovery.
• Gynecological & ENT Inflammations: Severe sinusitis, pharyngitis, and pelvic inflammatory conditions where heavy edema prevents antibiotic penetration.

Dosage & Administration

Recommended Dosage (Strictly as per Physician/Surgeon Guidelines):

• Standard Adult Dosing: One tablet taken 2 to 3 times a day (BID/TID), depending on the severity of the edema.
• Administration (THE MEALTIME RULE): To drastically reduce the risk of severe gastrointestinal ulceration caused by Diclofenac, this medication MUST be administered immediately after a full meal.
• Swallowing Protocol (CRITICAL HAZARD): The tablet MUST be swallowed whole with water. Chewing or crushing the tablet physically shatters the microscopic enteric coating on the Serratiopeptidase, exposing the enzyme to stomach acid and causing complete therapeutic failure.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• BLACK BOX WARNING (Cardiovascular Thrombosis): NSAIDs (including Diclofenac) massively increase the risk of serious, potentially fatal cardiovascular thrombotic events, myocardial infarction, and stroke. It is strictly contraindicated in the setting of coronary artery bypass graft (CABG) surgery.
• BLACK BOX WARNING (Gastrointestinal Bleeding): NSAIDs cause an increased risk of serious gastrointestinal adverse events, including bleeding, ulceration, and fatal perforation. Because this dual FDC lacks Paracetamol, the NSAID burden on the stomach is high.
• Bleeding Disorder Caution: Both Diclofenac (which affects platelets) and Serratiopeptidase (which breaks down fibrin clots) can severely prolong bleeding time. It must be used with extreme caution in patients taking strong anticoagulants (like Warfarin or Clopidogrel).

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Retail Pharmacy Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Analgesic Formulations. Whether you need a reliable Hospital Tender Supplier for surgical wards in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery of WHO-GMP certified products.